Related Experiment Video
Updated: Jun 13, 2025

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
Progressive vulnerability of cortical synapses in α-synucleinopathy
None:
α-Synuclein aggregates are a hallmark of multiple neurodegenerative disorders, including Parkinson's disease and dementia with Lewy bodies. Cortical pathology in these diseases correlates with cognitive decline. This pathology may progressively impact synaptic connectivity, and we tested this in the frontal cortex in a α-synucleinopathy model. High-resolution imaging showed that intracortical VGLUT1-positive excitatory synapses became increasingly vulnerable, exhibiting early loss near aggregates. The remaining intracortical excitatory synapses were structurally disrupted as measured by high-resolution imaging and electron microscopy. These effects were accompanied by synaptic α-syn accumulation. Ontology analysis of gene expression changes in pathology-bearing neurons showed altered synapse-related processes, with upregulated genes indicating candidate resilience mechanisms. Analyses informed by neuroanatomical connectivity provided additional insights. Mesoscans determined that synapse loss is correlated between cortical layer V and layer II/III, which includes neurons projecting to layer V. Analysis across cortical hemispheres supported a vulnerability of intratelencephalic (IT) projection neurons in layer V. In contrast to intracortical synapses, long-range VGLUT2+ excitatory synapses were spared. Inhibitory VGAT+ synapses were modestly impacted, with a late-stage reduction in postsynaptic specializations. Electrophysiological recordings validated impaired excitatory transmission. This study reveals progressive, synapse-type specific vulnerabilities and resilience and characterizes intracortical synapses as cellular locus of disrupted connectivity in α-synucleinopathy.
Related Concept Videos
Parkinson's Disease: Overview
Neural Regulation
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

